Clinical Research Directory
Browse clinical research sites, groups, and studies.
Population PK-guided ATG Dosing in Haplo-HSCT
Sponsor: Chinese PLA General Hospital
Summary
To evaluate the safety and efficacy of a population pharmacokinetics (PK)-guided targeted ATG dosing strategy in haploidentical stem cell transplantation and to observe the GVHD-free, relapse-free survival (GRFS) in the cohort receiving this strategy.
Official title: Pharmacokinetic Guided ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem-cell Transplantation
Key Details
Gender
All
Age Range
14 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
63
Start Date
2025-05-10
Completion Date
2027-12-30
Last Updated
2026-08-28
Healthy Volunteers
No
Conditions
Interventions
Anti Thymocyte Globulin
Population pharmacokinetic formula-guided targeted ATG dosing plus classical GVHD prophylaxis regimen
Locations (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, China